Symbol="TRVN"
AssetType="Common Stock"
Name="Trevena Inc"
Description="Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of new drugs for patients affected by disorders of the central nervous system. The company is headquartered in Chesterbrook, Pennsylvania."
CIK="1429560"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="955 CHESTERBROOK BOULEVARD, SUITE 110, CHESTERBROOK, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="10748500"
EBITDA="-49689000"
PERatio="None"
PEGRatio="0"
BookValue="1.131"
DividendPerShare="0"
DividendYield="0"
EPS="-6.06"
RevenuePerShareTTM="-0.055"
ProfitMargin="0"
OperatingMarginTTM="115.85"
ReturnOnAssetsTTM="-0.609"
ReturnOnEquityTTM="-1.515"
RevenueTTM="-432000"
GrossProfitTTM="-3436000"
DilutedEPSTTM="-6.06"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.7"
AnalystTargetPrice="29.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="106.03"
PriceToBookRatio="0.569"
EVToRevenue="18.8"
EVToEBITDA="0.132"
Beta="1.902"
num_52WeekHigh="6.47"
num_52WeekLow="0.58"
num_50DayMovingAverage="1.016"
num_200DayMovingAverage="1.749"
SharesOutstanding="10969000"
DividendDate="None"
ExDividendDate="None"
symbol="TRVN"
open="0.96"
high="0.96"
low="0.94"
price="0.95"
volume="104365.00"
latest_trading_day="2023-07-27"
previous_close="0.98"
change="-0.03"
change_percent="-3.0513%"
aroon_positive_momentum_days="56"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="56"
Volume_recent_avg="1842629"
Change_recent_avg="0.01"
Delta_recent_avg="0.13"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-1.63"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="56"
Aroon_momentum_negative="44"
image_negative_thumbnail_id_1="143"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0033.jpeg"
image_negative_thumbnail_id_2="135"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0041.jpeg"
image_neutral_thumbnail_id_1="533"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0066.jpeg"
image_neutral_thumbnail_id_2="592"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0007.jpeg"
image_positive_thumbnail_id_1="1006"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0168.jpeg"
image_positive_thumbnail_id_2="963"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0125.jpeg"
image_professor_thumbnail_id_1="1167"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
image_professor_thumbnail_id_2="1170"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
